Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

Phase Ii Study ◽

First Line ◽

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

10.1038/sj.bjc.6604121 ◽

2007 ◽

Vol 98 (1) ◽

pp. 71-76 ◽

Cited By ~ 28

Author(s):

S Cascinu ◽

R Berardi ◽

S Salvagni ◽

G D Beretta ◽

V Catalano ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicentre Phase ◽

First Line Treatment

A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients

Cancer Research and Treatment ◽

10.4143/crt.2018.379 ◽

2019 ◽

Vol 51 (3) ◽

pp. 1128-1134

Author(s):

Youjin Kim ◽

Tae Won Kim ◽

Sae Won Han ◽

Joong Bae Ahn ◽

Seung Tae Kim ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Phase II Study of Pulse 5-Fluoro-2′-Deoxyuridine and Leucovorin in Advanced Colorectal Cancer Patients Previously Treated with Chemotherapy

American Journal of Clinical Oncology ◽

10.1097/00000421-199204000-00004 ◽

1992 ◽

Vol 15 (2) ◽

pp. 115-118 ◽

Cited By ~ 1

Author(s):

John C. Marsh ◽

Henry J. Durivage ◽

Carol Davis ◽

Kyle OʼHollaren ◽

Dominick N. Pasquale ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Previously Treated ◽

5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group

Annals of Oncology ◽

10.1023/a:1008342928408 ◽

2000 ◽

Vol 11 (8) ◽

pp. 1045-1052 ◽

Cited By ~ 29

Author(s):

E. Maiello ◽

V. Gebbia ◽

F. Giuliani ◽

G. Paoletti ◽

N. Gebbia ◽

...

Keyword(s):

Colorectal Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Phase Ii ◽

Southern Italy ◽

Phase Ii Study ◽

Oncology Group ◽

Phase II study of Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin (SOX) + bevacizumab regimen for advanced colorectal cancer

Annals of Oncology ◽

10.1093/annonc/mdx393.139 ◽

2017 ◽

Vol 28 ◽

pp. v208

Author(s):

D. Manaka ◽

R. Nishitai ◽

S. Konishi ◽

T. Ohta ◽

T. Hattori ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Dose Control ◽

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

10.1038/sj.bjc.6603493 ◽

2007 ◽

Vol 96 (3) ◽

pp. 439-444 ◽

Cited By ~ 21

Author(s):

E Bajetta ◽

◽

M Di Bartolomeo ◽

R Buzzoni ◽

L Mariani ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients

10.1038/sj.bjc.6603204 ◽

2006 ◽

Vol 95 (1) ◽

pp. 13-20 ◽

Cited By ~ 16

Author(s):

M Tampellini ◽

A Saini ◽

I Alabiso ◽

R Bitossi ◽

M P Brizzi ◽

...

Keyword(s):

Colorectal Cancer ◽

Haemoglobin Level ◽

Cancer Patients ◽

First Line ◽

The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab

Annals of Oncology ◽

10.1093/annonc/mdq640 ◽

2010 ◽

Vol 21 (12) ◽

pp. 2447-2448 ◽

Cited By ~ 27

Author(s):

L.H.J. Simkens ◽

J. Tol ◽

L.W.M.M. Terstappen ◽

S. Teerenstra ◽

C.J.A. Punt ◽

...

Keyword(s):

Colorectal Cancer ◽

Endothelial Cells ◽

Cancer Patients ◽

Prognostic Value ◽

Circulating Endothelial Cells ◽

First Line ◽

Predictive And Prognostic Value ◽

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

BMC Cancer ◽

10.1186/s12885-018-4001-x ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 3

Author(s):

Francesca Battaglin ◽

Marta Schirripa ◽

Federica Buggin ◽

Filippo Pietrantonio ◽

Federica Morano ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type ◽

First Line ◽

Randomized Phase Ii ◽

A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients

10.1038/sj.bjc.6603095 ◽

2006 ◽

Vol 94 (9) ◽

pp. 1287-1292 ◽

Cited By ~ 32

Author(s):

M Mabro ◽

◽

P Artru ◽

T André ◽

M Flesch ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽